Rights and permissions
About this article
Cite this article
The orally-active platinum compound satraplatin [JM-216] shows no nephrotoxicity. Inpharma Wkly. 1223, 9 (2000). https://doi.org/10.2165/00128413-200012230-00021
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012230-00021